Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for ischemia with no obstructive coronary artery disease and microvascular dysfunction
2023-507981-17-00Phase 2Authorised
- Sponsor
- Capital Region of Denmark
- Start
- Dec 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Coronary Small Vessel Disease (CMD) comparing Colchicine with Placebo (2 arms). Planned start Dec 2023; status: authorised.
02
Drugs
colchicine
03
Conditions
Coronary Small Vessel Disease (CMD)
Beyond the preview
Go deeper on 2023-507981-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507981-17-00.